1. Федеральная служба государственной статистики. Демографический ежегодник России. Статистический сборник. М.: Росстат. 2023:256.
2. Cairns C, Kang K. National Hospital Ambulatory Medical Care Survey: emergency department summary tables. 2022:38.
3. Bhatt DL, Lopes RD, Harrington RA. Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022;327(7):662-75. doi:10.1001/jama.2022.0358. Erratum in: JAMA. 2022;327(17):1710. doi:10.1001/jama.2022.6185.
4. Hsia RY, Hale Z, Tabas JA. A National Study of the Prevalence of Life-Threatening Diagnoses in Patients With Chest Pain. JAMA Intern Med. 2016;176(7):1029-32. doi:10.1001/jamainternmed.2016.2498.
5. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-826. doi:10.1093/eurheartj/ehad191.
6. Januzzi JL Jr, Mahler SA, Christenson RH, et al. Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(9):1059-77. doi:10.1016/j.jacc.2018.12.046.
7. Gallacher PJ, Miller-Hodges E, Shah ASV, et al. Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment: A Randomized Clinical Trial. JAMA Intern Med. 2021;181(9):1237-9. doi:10.1001/jamainternmed.2021.1184.
8. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000;36(3):970-1062. doi:10.1016/s0735-1097(00)00889-5.
9. Khan AR, Golwala H, Tripathi A, et al. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. Eur Heart J. 2017;38(41):3082-9. doi:10.1093/eurheartj/ehx418.
10. Aslanger EK, Yıldırımtürk Ö, Şimşek B, et al. DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study).Int J Cardiol Heart Vasc. 2020;30:100603. doi:10.1016/j.ijcha.2020.100603.
11. Larson DM, Menssen KM, Sharkey SW, et al. "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA. 2007;298(23):2754-60. doi:10.1001/jama.298.23.2754.
12. McCabe JM, Armstrong EJ, Kulkarni A, et al. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention–capable centers: a report from the Activate-SF registry. Arch Intern Med. 2012;172(11):864-71. doi:10.1001/archinternmed.2012.945.
13. Möckel M. The new ESC acute coronary syndrome guideline and its impact in the CPU and emergency department setting. Die neue ESC-Leitlinie zum akuten Koronarsyndrom und ihre Auswirkungen auf die Chest Pain Unit und zentrale Notaufnahme. Herz. 2024;49(3):185-9. doi:10.1007/s00059-024-05241-6.
14. Зайцев А. Д., Коротаева Е. С., Королева Л. Ю. и др. Предикторы госпитальной летальности у пациентов с острым коронарным синдромом. Российский кардиологический журнал. 2024;29(S8):251. EDN: XIEWOS.
15. Коротаева Е. С., Зайцев А. Д., Королева Л. Ю. и др. Многофакторное прогнозирование риска госпитальной летальности у пациентов с острым коронарным синдромом. Кардиология. 2025;65(2):17-25. doi:10.18087/cardio.2025.2.n2788.
16. Jeger RV, Pfister O, Radovanovic D, et al. Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry. Clin Cardiol. 2017;40(10):907-13. doi:10.1002/clc.22745.
17. Harjola VP, Parissis J, Bauersachs J, et al. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22(8):1298-314. doi:10.1002/ejhf.1831.
18. Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol. 2005;45(9):1397-405. doi:10.1016/j.jacc.2005.01.041.
19. Bahit MC, Lopes RD, Clare RM, et al. Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes. JACC Heart Fail. 2013;1(3):223-9. doi:10.1016/j.jchf.2013.02.007.
20. Brusca SB, Zou Y, Elinoff JM. How low should we go? Potential benefits and ramifications of the pulmonary hypertension hemodynamic definitions proposed by the 6th World Symposium. Curr Opin Pulm Med. 2020;26(5):384-90. doi:10.1097/MCP.0000000000000699.
21. Vanden Eynden F, Racapé J, Vincent J, et al. The linear relationship between systolic pulmonary artery pressure and mean pulmonary artery pressure is maintained regardless of autonomic or rhythm disturbances. Respir Res. 2016;17:33. doi:10.1186/s12931-016-0350-7.
22. Mathai SC, Ryan JJ. The Growing Burden of Pulmonary Hypertension in the Modern Era: A Zebra No More? Circ Cardiovasc Qual Outcomes. 2018;11(2):e004536. doi:10.1161/CIRCOUTCOMES.118.004536.
23. Jentzer JC, Wiley BM, Reddy YNV, et al. Epidemiology and outcomes of pulmonary hypertension in the cardiac intensive care unit. Eur Heart J Acute Cardiovasc Care. 2022;11(3):230-41. doi:10.1093/ehjacc/zuab127.
24. Драпкина О. М., Концевая А. В., Калинина А. М. и др. Коморбидность пациентов с хроническими неинфекционными заболеваниями в практике врача-терапевта. Евразийское руководство. Кардиоваскулярная терапия и профилактика. 2024;23(3):3996. doi:10.15829/1728-8800-2024-3996.
25. Breen K, Finnegan L, Vuckovic K, et al. Multimorbidity in Patients With Acute Coronary Syndrome Is Associated With Greater Mortality, Higher Readmission Rates, and Increased Length of Stay: A Systematic Review. J Cardiovasc Nurs. 2020;35(6):E99-E110. doi:10.1097/JCN.0000000000000748.
26. Blanc B, Finch CA, Hallberg L, et al. Nutritional anaemias. Report of a WHO Scientific Group. WHO Tech Rep Ser. 1968;405:1-40.
27. Stucchi M, Cantoni S, Piccinelli E, et al. Anemia and acute coronary syndrome: current perspectives. Vasc Health Risk Manag. 2018;14:109-18. doi:10.2147/VHRM.S140951.
28. Guedeney P, Sorrentino S, Claessen B, et al. The link between anemia and adverse outcomes in patients with acute coronary syndrome. Expert Rev Cardiovasc Ther. 2019;17(3):151-9. doi:10.1080/14779072.2019.1575729.
29. Scott JK, Johnson T, Caskey FJ, et al. Association between kidney function, frailty and receipt of invasive management after acute coronary syndrome. Open Heart. 2024;11(2):e002875. doi:10.1136/openhrt-2024-002875.
30. Smilowitz NR, Gupta N, Guo Y, et al. Management and outcomes of acute myocardial infarction in patients with chronic kidney disease. Int J Cardiol. 2017;227:1-7. doi:10.1016/j.ijcard.2016.11.026.
31. Su H, Ji L, Xing W, et al. Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein. J Cell Mol Med. 2013;17(1):181-91. doi:10.1111/j.1582-4934.2012.01661.x.
32. Баланова Ю. А., Драпкина О. М., Куценко В. А. и др. Ожирение в российской популяции в период пандемии COVID-19 и факторы, с ним ассоциированные. Данные исследования ЭССЕ-РФ3. Кардиоваскулярная терапия и профилактика. 2023;22(8S):3793. doi:10.15829/1728-8800-2023-3793.
33. Chang VW, Langa KM, Weir D, et al. The obesity paradox and incident cardiovascular disease: A population-based study. PLoS One. 2017;12(12):e0188636. doi:10.1371/journal.pone.0188636.
34. Abohashem S, Sayed A, Aldosoky W, et al. Burden and disparities in cardiovascular mortality rates associated with obesity prevalence in United States: county-level analysis from 2010 to 2019. European Heart Journal. 2022;43(2):ehac544.2398. doi:10.1093/eurheartj/ehac544.2398.